This 56th issue of the Foundation’s newsletter describes two aspects that are of increasing importance in pharmacological research and neurological practice: the repositioning/repurposing of existing medications for the treatment of MS (Prof. Muccioli), and the use of telemedicine to monitor and measure the progression of clinical symptoms (Prof. Nagels and his team).
Download it here
You raised more than 7.5 months' worth of funds for multiple sclerosis research!
Here are a few photos of the event, made all the more special by your presence.
From all the researchers: Thank you!
All participants join us in paying tribute to our volunteers: Diane, Louise, Véronique, Tykhon, Joachim, Charles-Henry and Professor Christian Sindic.
Finally, we dedicate this edition to Isabelle Bloem, who, for reasons beyond her control was unable to join this event but whose every aspect bears her imprint.
Statistics:
The Belgian Charcot Foundation is funding 7 new projects...
A few decades ago, pregnancy was not recommended for women suffering from MS. This is no longer the case.
Giving birth to one or more children while suffering from MS has no negative consequences on the course of the disease, and on the contrary could have a positive effect on it...
Multiple sclerosis (MS) is an explosive mix : MS involves the Epstein-Barr virus, autoimmunity, neuroinflammation and cerebral atrophy, all at once.
But the existence of "shadow plaques" is a source of hope...Explanations...
